Suvoda Announces General Availability of New eCOA Solution
Suvoda has announced the general availability of its electronic clinical outcome assessments (eCOA) product that delivers simplified questionnaire licensing and localizations, streamlined device logistics, and improved data integrity. Click to tweet.
Suvoda eCOA is delivered on a single platform with Suvoda IRT and eConsent, and is designed to work with these products to help clinical trial sponsors and sites manage complex clinical trials and focus more time on patient interactions.
Reference
Suvoda Announces General Availability of Powerful New eCOA Solution. (2023, May 23). Cision PR Newswire.
Putting Collective Insights Into Action to Advance Cancer Care: Key Examples From ASCO 2025
June 27th 2025At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Funding Cuts Threaten Diversity in Clinical Research
June 27th 2025In this video interview, Kyle McAllister, co-founder, CEO, Trially, discusses how recent federal funding cuts are likely to undermine research focused on underrepresented populations, and why long-term investment in community-based studies is essential to closing persistent health equity gaps.
